Respiratory infections remain a major global health challenge, with overlapping symptoms often making clinical diagnosis difficult. RPP40 addresses this challenge by leveraging advanced molecular diagnostic technology to simultaneously test for a wide range of respiratory viruses and bacteria — f...
EXPLORE NOWInterested to Know More about Our Solution to Molecular Diagnostics?